Jupiter Life Line Hospitals Limited (NSE:JLHL)

India flag India · Delayed Price · Currency is INR
1,460.30
+4.50 (0.31%)
Jul 13, 2026, 10:10 AM IST
Market Cap95.45B -4.0%
Revenue (ttm)15.00B +15.2%
Net Income1.94B +0.4%
EPS29.59 +0.4%
Shares Out 65.57M
PE Ratio49.20
Forward PE42.24
Dividend1.00 (0.07%)
Ex-Dividend DateMay 22, 2026
Volume14,022
Open1,448.00
Previous Close1,455.80
Day's Range1,441.00 - 1,462.10
52-Week Range1,178.00 - 1,625.00
Beta0.19
AnalystsStrong Buy
Price Target1,595.83 (+9.28%)
Earnings DateJul 31, 2026

About NSE:JLHL

Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurger... [Read more]

Sector Healthcare
Founded 2002
Employees 3,002
Stock Exchange National Stock Exchange of India
Ticker Symbol JLHL
Full Company Profile

Financial Performance

In fiscal year 2026, NSE:JLHL's revenue was 15.00 billion, an increase of 15.16% compared to the previous year's 13.02 billion. Earnings were 1.94 billion, an increase of 0.42%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for JLHL stock is "Strong Buy." The 12-month stock price target is ₹1,596, which is an increase of 9.28% from the latest price.

Price Target
₹1,596
(9.28% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Jupiter Life Line Hospitals Transcript: Q4 25/26

FY 2026 saw strong 15%+ growth in revenue and EBITDA, with robust expansion plans adding 1,700 beds across Mumbai and Pune. Dombivli hospital opened ahead of schedule, and the group remains cash positive, funding growth through internal accruals and capped debt.

7 weeks ago - Transcripts

Jupiter Life Line Hospitals Quarterly report: Q4 2026

Jupiter Life Line Hospitals has published its Q4 2026 quarterly earnings report on May 18, 2026.

7 weeks ago - Filings

Jupiter Life Line Hospitals Slides: Q4 2026

Jupiter Life Line Hospitals has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 18, 2026.

7 weeks ago - Filings

Jupiter Life Line Hospitals Annual report: Q4 2026

Jupiter Life Line Hospitals has published its Q4 2026 annual report on May 18, 2026.

7 weeks ago - Filings

Jupiter Life Line Hospitals Transcript: Q3 25/26

Dombivli hospital launched ahead of schedule, but will initially weigh on margins as it ramps up. Q3 saw 9.8% revenue growth and stable EBITDA margins, though PAT declined due to a one-time labor code provision. Mature hospitals are stable, while Indore and new projects drive future growth.

5 months ago - Transcripts

Jupiter Life Line Hospitals Quarterly report: Q3 2026

Jupiter Life Line Hospitals has published its Q3 2026 quarterly earnings report on February 1, 2026.

5 months ago - Filings

Jupiter Life Line Hospitals Slides: Q3 2026

Jupiter Life Line Hospitals has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 1, 2026.

5 months ago - Filings

Jupiter Life Line Hospitals Transcript: Q2 25/26

Q2 and H1 FY26 saw double-digit revenue and EBITDA growth, with margins stable despite new bed additions. Dombivli Hospital is on track for Q1 launch next year, with new accounting for unbilled revenue and a one-off provision impacting results. Debt remains low-cost and well-covered by liquidity.

8 months ago - Transcripts

Jupiter Life Line Hospitals Quarterly report: Q2 2026

Jupiter Life Line Hospitals has published its Q2 2026 quarterly earnings report on November 10, 2025.

8 months ago - Filings

Jupiter Life Line Hospitals Slides: Q2 2026

Jupiter Life Line Hospitals has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 10, 2025.

8 months ago - Filings

Jupiter Life Line Hospitals Transcript: Q1 25/26

Q1 FY26 saw 20.5% revenue growth and 19.6% EBITDA growth, but PAT declined 1.6% due to higher depreciation and finance costs. Occupancy and patient volumes rose, with strong ARPOB growth from price hikes and case mix. Renewable energy investments and greenfield expansions continue.

1 year ago - Transcripts

Jupiter Life Line Hospitals Quarterly report: Q1 2026

Jupiter Life Line Hospitals has published its Q1 2026 quarterly earnings report on August 4, 2025.

1 year ago - Filings

Jupiter Life Line Hospitals Slides: Q1 2026

Jupiter Life Line Hospitals has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on August 4, 2025.

1 year ago - Filings